154 related articles for article (PubMed ID: 9531670)
1. [Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
Biller B; Hörauf A; Kraft W
Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Feb; 26(1):21-30. PubMed ID: 9531670
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
[TBL] [Abstract][Full Text] [Related]
3. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Ettinger SJ; Benitz AM; Ericsson GF; Cifelli S; Jernigan AD; Longhofer SL; Trimboli W; Hanson PD
J Am Vet Med Assoc; 1998 Dec; 213(11):1573-7. PubMed ID: 9838955
[TBL] [Abstract][Full Text] [Related]
4. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
J Vet Intern Med; 1995; 9(4):234-42. PubMed ID: 8523320
[TBL] [Abstract][Full Text] [Related]
5. Decreased sympathetic tone after short-term treatment with enalapril in dogs with mild chronic mitral valve disease.
Chompoosan C; Buranakarl C; Chaiyabutr N; Chansaisakorn W
Res Vet Sci; 2014 Apr; 96(2):347-54. PubMed ID: 24559801
[TBL] [Abstract][Full Text] [Related]
6. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
7. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group.
J Vet Intern Med; 1995; 9(4):243-52. PubMed ID: 8523321
[TBL] [Abstract][Full Text] [Related]
8. Effect of enalapril in dogs with pacing-induced heart failure.
Allworth MS; Church DB; Maddison JE; Einstein R; Brennan P; Abdul Hussein N; Matthews R
Am J Vet Res; 1995 Jan; 56(1):85-94. PubMed ID: 7695155
[TBL] [Abstract][Full Text] [Related]
9. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
Atkins CE; Keene BW; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards NJ; Fox PR; Lehmkuhl LB; Luethy MW; Meurs KM; Petrie JP; Pipers FS; Rosenthal SL; Sidley JA; Straus JH
J Am Vet Med Assoc; 2007 Oct; 231(7):1061-9. PubMed ID: 17916031
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the effects of digoxin or enalapril in the treatment of heart failure due to mitral insufficiency].
Lanas F; Garcés E; Eggers G; Montecinos A; Díaz M; Gamboa C; Stockins B
Rev Med Chil; 1998 Mar; 126(3):251-7. PubMed ID: 9674293
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
[TBL] [Abstract][Full Text] [Related]
12. [Oral enalapril in patients with symptomatic ventricular septal defects].
Vázquez-Antona CA; Simón Ruiz S; Rijlaarsdam M; Miranda Chávez I; Leiva JL; Buendía A; Attie F
Arch Inst Cardiol Mex; 1996; 66(6):496-504. PubMed ID: 9133310
[TBL] [Abstract][Full Text] [Related]
13. [ACE inhibitors in dogs with subclinical chronic mitral insufficiency].
Kvart C; Häggström J; Pedersen HD
Tijdschr Diergeneeskd; 2003 Feb; 128(3):76-7. PubMed ID: 12616901
[No Abstract] [Full Text] [Related]
14. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
15. Geriatric heart diseases in dogs.
Hamlin RL
Vet Clin North Am Small Anim Pract; 2005 May; 35(3):597-615. PubMed ID: 15833561
[TBL] [Abstract][Full Text] [Related]
16. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
Moesgaard SG; Pedersen LG; Teerlink T; Häggström J; Pedersen HD
J Vet Intern Med; 2005; 19(5):712-9. PubMed ID: 16231716
[TBL] [Abstract][Full Text] [Related]
17. Mitral valve prolapse in Cavalier King Charles spaniel: a review and case study.
Hyun C
J Vet Sci; 2005 Mar; 6(1):67-73. PubMed ID: 15785126
[TBL] [Abstract][Full Text] [Related]
18. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
19. The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
Ishikawa T; Tanaka R; Suzuki S; Miyaishi Y; Akagi H; Iino Y; Fukushima R; Yamane Y
J Vet Intern Med; 2010; 24(2):342-7. PubMed ID: 20102507
[TBL] [Abstract][Full Text] [Related]
20. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
